FDA modernization policy issues; General issues related to rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases.
2026 · 1st Quarter (Jan 1 - Mar 31)
STANTON PARK GROUP LLC ON BEHALF OF KYOWA KIRIN
Filed by DGSR LLC.
Open official filingSource-reported fields
Filing overview
- Type
- Registration
- Posted
- Mar 27, 2026
- Income
- Not reported
- Expenses
- Not reported
- Registrant
- DGSR LLC
- Filing UUID
- 47baf533-1652-4d59-ae8e-96e738876f07
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.